# Accidental Drug Deaths Connecticut
Accidental death associated with drug overdose in Connecticut from 2012 to 2022.

## Overview

This analysis focuses on accidental drug-related deaths in Connecticut from 2012 to 2022. The dataset is derived from investigations conducted by the Office of the Chief Medical Examiner. The aim is to provide insights into various aspects of accidental drug deaths, including demographics, substances involved, geographical distribution, and common circumstances surrounding these tragic incidents.

## Data Source

The dataset used for this analysis can be found here: https://catalog.data.gov/dataset/accidental-drug-related-deaths-2012-2018
It includes information about accidental drug-related deaths, offering a comprehensive view of the issue in Connecticut.

## Key Findings

## Demographics

Gender Distribution:
Men: 7,888 deaths
Women: 2,754 deaths

Age Range:
The age of victims ranged from 13 to 87.

Heroin-Related Deaths
Heroin involved in 3,472 deaths.
Heroin mentioned on the death certificate in 740 cases.

Opioid-Related Deaths
7,609 deaths involved any opioid out of a total of 10,651 accidental drug-related deaths.

## Geographical Distribution

Highest Death Count:
Hartford, Connecticut had the highest death count.
Lowest Death Count:
Danbury, Connecticut had the lowest death count.

Substances Involved
Fentanyl Dominance:
Fentanyl was the most common substance involved in deaths.

Circumstances
Location of Deaths:
The most common location for victims was at their residence.

## Closing

This analysis sheds light on the significant impact of accidental drug-related deaths in Connecticut over the past decade. The data provides valuable insights into the demographics of the affected population, the prevalence of specific substances like heroin and fentanyl, and the geographical distribution of these incidents.

Understanding the patterns revealed in this analysis can inform public health initiatives, law enforcement efforts, and community-based interventions to address the root causes and reduce the occurrence of accidental drug-related deaths.
